Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.00
Bid: 61.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.557%)
Open: 63.00
High: 63.00
Low: 63.00
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealing Notification

18 Apr 2018 17:08

RNS Number : 3812L
NetScientific PLC
18 April 2018
 

18 April 2018

NetScientific plc

 

Directors Dealing Notification

 

NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation group, announces that on 17 April 2018 it received notification that Sir Richard Sykes, Barry Wilson, and Steve Smith (the "Directors"), subscribed for New Ordinary Shares (the "Shares") in the NetScientific Placing and Subscription (the "Placing") at a price of 52.5 pence per Share, with the Shares admitted to trading on AIM on 17 April 2018.

 

The details of the Directors' shareholdings in the Company following the Placing are as follows:

 

 

No. of Ordinary Shares as at 28 March 2018

(date of announcement of conditional Placing)

No. of New Ordinary Shares subscribed

No. of Ordinary Shares as at Admission

Percentage of enlarged share capital as at Admission

Sir Richard Sykes

62,500

30,952

93,452

0.12%

Barry Wilson

36,358

30,952

67,310

0.09%

Professor Stephen Smith

-

28,571

28,571

0.04%

 

The total number of voting rights in NetScientific is 78,561,866.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Sir Richard Sykes

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director - Chairman)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Barry Wilson

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Steve Smith

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 28,571

 

d)

 

Aggregated information

 

Aggregated volume

 

 28,571

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

For more information, please contact:

 

NetScientific plc

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800

Consilium Strategic Communications

Mary-Jane Elliott/Jessica Hodgson

Chris Welsh/Laura Thornton

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Bookrunner)

Jonathan Senior/David Arch/Ben Maddison

 Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Placing Agent)

David Parsons/Christopher Britton/Bidhi Bhoma/Euan Brown

Tel: +44 (0)20 3709 5700

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUAUCUPRGQR
Date   Source Headline
15th Apr 20247:00 amRNSProAxsis secures c.£1.8mn investment
27th Mar 20241:34 pmRNSPDS Strategy Update and 2023 Financial Results
13th Mar 20247:00 amRNSBusiness Update
5th Feb 20247:00 amRNSExercise of Options and Issue of Shares
23rd Jan 20247:00 amRNSGlycotest secures $1 million investment
1st Dec 20237:00 amRNSDeepTech Recycling secures £1 million investment
14th Nov 20234:39 pmRNSPDS BioTechnology: Third Quarter Results
13th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20235:28 pmRNSPDS Biotech Announces Updated Survival Data
6th Nov 20237:00 amRNSVentive secures c.£900,000 investment
2nd Nov 20237:00 amRNSChange of Adviser
23rd Oct 20236:22 pmRNSPDS Preliminary Biomarker Study Results
13th Oct 20237:00 amRNSExercise of Options
3rd Oct 20234:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20233:21 pmRNSPDS: Interim 24-month survival rate of 74% update
3rd Oct 20237:00 amRNSPDS Biotech: new data on PDS0101
28th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSQ-Bot: £3.5 million investment to drive expansion
14th Aug 20235:55 pmRNSPDS Biotech: 2nd Quarter Results, Business Update
14th Aug 20235:51 pmRNSPDS Biotech: Submission of Phase 3 Protocol to FDA
3rd Jul 20237:00 amRNSGrant of Options, Issue of Shares, Director/PDMR
30th Jun 20237:00 amRNSDName-iT Holdings Limited Fundraising
29th Jun 202311:04 amRNSResult of AGM & Board Changes
22nd Jun 20237:00 amRNSVortex Fundraising
14th Jun 20233:31 pmRNSPDS Announces Achievement of Efficacy Threshold
7th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSNotice of AGM
31st May 20237:01 amRNSPreliminary Results for the year ended 31 Dec 2022
31st May 20237:00 amRNSBoard Changes
26th May 20239:39 amRNSPDS Biotech Announces Interim Data
24th May 20237:00 amRNSSofant and Inmarsat announce joint development
15th May 20233:16 pmRNSPDS Business Update and First Quarter Results
2nd May 20237:00 amRNSGlycotest, Inc. Fundraising
3rd Apr 20237:00 amRNSBusiness Update
30th Mar 20233:51 pmRNSPDS Update
28th Mar 20233:50 pmRNSPDS Business Update and 2022 Financial Results
28th Feb 20237:00 amRNSRelated party loan to ProAxsis Limited
27th Feb 20233:28 pmRNSPDS completes FDA meeting for triple combination
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSBoard Change
3rd Jan 20231:31 pmRNSPDS Announces Exclusive Global License Agreement
28th Dec 20223:05 pmRNSPDS Biotech: Median Overall Survival announcement
16th Dec 20227:00 amRNSPDS: HPV16 Head and Neck Cancer announcement
12th Dec 20222:00 pmRNSBoard Changes; Options; Co-Investment Agreement
29th Nov 20227:00 amRNSEMV C leads £4.2m round in 5G and SATCOM leader
14th Nov 20222:50 pmRNSPDS Q3 Results and Business Update
14th Nov 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.